Not Rated
|
Fund Size
(0.16% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 20-Oct-25 | 9916.10 | -0.84% | - | 0.36% | 212/227 |
| 1 Month | 26-Sep-25 | 10260.30 | 2.60% | - | 4.01% | 187/227 |
| 3 Month | 28-Jul-25 | 9884.70 | -1.15% | - | 4.43% | 210/222 |
| 6 Month | 28-Apr-25 | 10397.20 | 3.97% | - | 10.57% | 199/213 |
| YTD | 01-Jan-25 | 9766.40 | -2.34% | - | 5.62% | 170/201 |
| 1 Year | 28-Oct-24 | 10052.80 | 0.53% | 0.53% | 6.35% | 149/184 |
| 2 Year | 27-Oct-23 | 15544.00 | 55.44% | 24.60% | 22.91% | 49/141 |
| 3 Year | 28-Oct-22 | 18545.20 | 85.45% | 22.84% | 21.13% | 37/117 |
| 5 Year | 28-Oct-20 | 22678.60 | 126.79% | 17.78% | 23.90% | 79/92 |
| Since Inception | 10-Jul-19 | 34290.00 | 242.90% | 21.58% | 14.64% | 36/198 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 28-Oct-24 | 12000 | 12457.78 | 3.81 % | 7.13 % |
| 2 Year | 27-Oct-23 | 24000 | 27088.85 | 12.87 % | 12.09 % |
| 3 Year | 28-Oct-22 | 36000 | 48600.68 | 35 % | 20.47 % |
| 5 Year | 28-Oct-20 | 60000 | 94117.32 | 56.86 % | 18.04 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 926.4 | 11.17% | 0.21% | 15.37% (Apr 2025) | 10.96% (Aug 2025) | 5.81 L | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 629.3 | 7.59% | -0.06% | 7.65% (Aug 2025) | 5.89% (Oct 2024) | 84.94 k | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 566.9 | 6.83% | -0.26% | 9.11% (Jan 2025) | 6.73% (Jul 2025) | 3.77 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 463.1 | 5.58% | 0.43% | 5.61% (Nov 2024) | 4.14% (Jan 2025) | 4.78 L | 0.00 |
| Abbott India Ltd. | Pharmaceuticals | 378.8 | 4.57% | -0.25% | 6.92% (Jun 2025) | 2.57% (Jan 2025) | 12.93 k | 0.00 |
| Lupin Ltd. | Pharmaceuticals | 375 | 4.52% | 0.12% | 5.19% (Dec 2024) | 4.07% (Oct 2024) | 1.96 L | 0.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 369.1 | 4.45% | 0.14% | 8.61% (Jan 2025) | 4.31% (Aug 2025) | 1.02 L | 0.00 |
| Ajanta Pharma Limited | Pharmaceuticals | 311.2 | 3.75% | -0.04% | 4.58% (Nov 2024) | 3.75% (Sep 2025) | 1.29 L | 0.00 |
| Ipca Laboratories Ltd. | Pharmaceuticals | 294.8 | 3.55% | -0.05% | 4.19% (Dec 2024) | 3.55% (Sep 2025) | 2.20 L | 0.00 |
| Anthem Biosciences Ltd. | Biotechnology | 267.1 | 3.22% | -0.18% | 3.4% (Aug 2025) | 0% (Oct 2024) | 3.51 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 1.90% |
| Net Receivables | Net Receivables | -0.24% |
Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 406.67 | 8.82 | 30.83 | 78.24 | 53.56 | 45.34 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 266.19 | 2.62 | 9.56 | 24.80 | 31.59 | 19.35 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1651.55 | 2.56 | 12.05 | 30.04 | 23.39 | 0.00 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 289.73 | 1.18 | 9.00 | 16.50 | 22.39 | 20.16 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7024.28 | 4.10 | 6.23 | 15.42 | 21.29 | 0.00 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 279.13 | 5.01 | 10.74 | 26.77 | 21.13 | 19.68 |
| Motilal Oswal Business Cycle Fund - Direct Plan - Growth | NA | 1984.52 | 8.58 | 6.32 | 15.56 | 18.73 | 0.00 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 655.17 | 5.11 | 5.96 | 19.71 | 18.70 | 0.00 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1419.62 | 5.49 | 6.13 | 10.38 | 18.08 | 0.00 |
| UTI Transportation and Logistics Fund - Direct Plan - Growth | NA | 3967.67 | 1.56 | 11.67 | 23.58 | 17.41 | 25.41 |
Out of 97 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 2 is/are ranked 4 * , 8 is/are ranked 3 * , 12 is/are ranked 2 * , 6 is/are ranked 1 * , and 67 schemes are not ranked. See more about AMC